It appears no script is enabled within your browser. Please enable JavaScript to use this site.
Skip header and navigation
Home
View Selections:
0
Items
Help
Print
Respiratory syncytial virus prophylaxis in Down syndrome: a prospective cohort study.
https://arctichealth.org/en/permalink/ahliterature104344
Source
Pediatrics. 2014 Jun;133(6):1031-7
Publication Type
Article
Date
Jun-2014
More detail
Author
Hao Yi
Krista L Lanctôt
Louis Bont
Beatrijs L P Bloemers
Michel Weijerman
Chantal Broers
Abby Li
Alexander Kiss
Ian Mitchell
Bosco Paes
Author Affiliation
Medical Outcomes and Research in Economics Research Group, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada;
Source
Pediatrics. 2014 Jun;133(6):1031-7
Date
Jun-2014
Language
English
Publication Type
Article
Keywords
Antibodies, Monoclonal, Humanized - adverse effects - therapeutic use
Birth weight
Canada
Child
Cohort Studies
Cross-Sectional Studies
Down Syndrome - complications - epidemiology
Female
Gestational Age
Hospitalization - statistics & numerical data
Humans
Incidence
Infant
Infant, Newborn
Infant, Premature, Diseases - epidemiology - prevention & control
Male
Netherlands
Prospective Studies
Registries
Respiratory Syncytial Virus Infections - epidemiology - prevention & control
Risk factors
Abstract
Children with Down syndrome (DS) are at significant risk for respiratory syncytial virus (RSV) infection and related hospitalization. We compared hospitalization rates due to respiratory tract infection in children with DS aged
PubMed ID
24799541
View in PubMed
Less detail
Permalink